Novavax Stock Plunges 25% As Vaccine Maker Has ‘Substantial Doubt’ About Staying In Business

  • 📰 Forbes
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 53%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Shares of the pharmaceutical company have slipped below $7 after trading well above $300 at points in 2021.

Shares of Novavax fell more than 25% in after-hours trading Tuesday, following a dismal fourth quarter earnings report and a

Novavax reported fourth quarter losses of $182 million after only posting $357 million in sales—well below expectations of $383 million.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 394. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Monster Beverage stock dives 6% as earnings and sales miss, stock split and price increases plannedMonster Beverage Corp. shares dove 6% in after-hours trading Tuesday, after the energy-drink company reported holiday earnings and sales lower than Wall...
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »